Drug Approval | January 03, 2024
Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24
The company has received five final approvals
The company has received five final approvals
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
10+ emerging markets, Japan & ANZ transition in final phase
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
GMM Pfaudler US completes acquisition of MixPro
Subscribe To Our Newsletter & Stay Updated
